Gene · 79885
Papers2,024
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,024
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structure-guided identification of histone deacetylase 11 inhibitors for targeted chemotherapy through long-timescale molecular dynamics simulation. | J Mol Model | 2026 | 42747587 | PubTator, text mining | PubMed |
| The histone deacetylase family in health and disease. | Signal Transduct Target Ther | 2026 | 42736262 | PubTator, text mining | PubMed |
| Critical structural features of HDAC11 inhibitors. | Methods Enzymol | 2026 | 42692754 | PubTator, text mining | PubMed |
| Comparative transcriptomics analysis of histone deacetylases, transcription factors, and ion channel genes in human iPSC-cardiomyocytes vs. the adult human heart. | J Precis Med (Amst) | 2026 | 42644057 | PubTator, text mining | PubMed |
| Design, synthesis, and evaluation of anti-solid-tumor activity of niclosamide-based STAT3/HDAC dual-target inhibitors. | Bioorg Chem | 2026 | 42526131 | PubTator, text mining | PubMed |
| AARS1-catalyzed H4K12 lactylation promotes HCC resistance to targeted therapy by activating RAPGEF3-RAP1 signaling. | Cell Death Dis | 2026 | 42481450 | PubTator, text mining | PubMed |
| Distillation enables scalable high-fidelity virtual screening across ultra-large chemical libraries. | bioRxiv | 2026 | 42427611 | PubTator, text mining | PubMed |
| HDAC11 as a potential therapeutic target for Alzheimer's disease. | Drug Discov Today | 2026 | 42398801 | PubTator, text mining | PubMed |
| Integrative transcriptomic and CRISPR dependency analysis identifies hepatoblastoma-specific essential genes and actionable vulnerabilities. | Cancer Genet | 2026 | 42385356 | PubTator, text mining | PubMed |
| Functional divergence and structural changes of Class IV histone deacetylases (HDACs) across the tree of life. | Mol Biol Evol | 2026 | 42308148 | PubTator, text mining | PubMed |
| The impactful role of the HDACs in the regulation of gene expression and as targets for disease therapy. | Sci Adv | 2026 | 42247509 | PubTator, text mining | PubMed |
| Hypoxia-mediated epigenetic silencing of YTHDF2 promotes endometriosis progression via the NFE2L1-NF-κB axis. | Int J Biol Macromol | 2026 | 42162597 | PubTator, text mining | PubMed |
| HDAC Inhibitors in Hematological and Solid Tumor Therapy: Current Success, Challenges, and Future Directions. | Curr Top Med Chem | 2026 | 42136451 | PubTator, text mining | PubMed |
| Super-enhancer-associated lncRNA HDAC11-AS1 aggravates hepatocellular carcinoma progression by modulating HDAC11 and NUP210 expression via promoting super-enhancer activity. | Cell Oncol (Dordr) | 2026 | 42126774 | PubTator, text mining | PubMed |
| HDAC11 Regulates RNA Splicing via De-Fatty Acylation of SF3B2. | bioRxiv | 2026 | 42124652 | PubTator, text mining | PubMed |
| Hdac11 promotes idiopathic pulmonary fibrosis through macrophage M2-type polarization and myofibroblast accumulation by inhibiting Parkin-dependent mitophagy. | Nat Commun | 2026 | 41997918 | PubTator, text mining | PubMed |
| Shared and distinct effects of mood stabilizers on epigenetic machinery gene expression: an exploratory study in HeLa cells. | Eur Neuropsychopharmacol | 2026 | 41955765 | PubTator, text mining | PubMed |
| Estrogen, Epigenetics, and Cardiometabolic Health: Mechanisms and Therapeutic Strategies in Postmenopausal Women. | Cells | 2026 | 41892319 | PubTator, text mining | PubMed |
| Single-cell profiling of HDAC inhibitor-induced EBV lytic heterogeneity defines abortive and refractory states in B lymphoblasts. | PLoS Pathog | 2026 | 41871169 | PubTator, text mining | PubMed |
| TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size. | Nat Immunol | 2026 | 41862649 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79885/papers